Sucampo Pharmaceuticals, Inc. Issues Statement Regarding Anesthetic and Analgesic Drug Products Advisory Committee Meeting's Vote
BETHESDA, Md., June 12, 2014 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo) (Nasdaq:SCMP), a global biopharmaceutical company, today issued the following statement regarding the Anesthetic and Analgesic Drug Products Advisory Committee (Advisory Committee) meeting's vote:
Help employers find you! Check out all the jobs and post your resume.